vTv Therapeutics Announces Larry Altstiel To Serve As Chief Medical Officer

HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that Larry Altstiel has joined the company as Chief Medical Officer. Altstiel brings decades of pharmaceutical industry experience and medical expertise to vTv, including serving in senior research and management roles at Pfizer Inc. and Eli Lilly Company. Most recently, Altstiel was Chief Executive Officer of Provectra Biotherapeutics where he led the company's mission in developing gene therapy for neuro-degenerative diseases.

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i